semaglutide 2.4 mg weekly Two-year effects of in adults with overweight or obesity: the STEP 5 trial Online—Once-weekly semaglutide 2·4 mg in

Research from the STEP 1 trial published in the New England Journal of Medicine showed that only 4.3 percent of participants discontinued treatment due to GI adverse events when following the proper titration schedule

This loss occurs primarily because: The body may break down muscle tissue during rapid weight loss Reduced caloric intake can affect muscle preservation Changes in metabolism may influence muscle function Medical experts emphasize that proper protein intake and regular exercise can help maintain muscle strength during treatment

Under the medical leadership of Dr

Quick Answer: GLP-1 medications can cause heartburn in some patients, with dyspepsia and GERD reported in approximately 3-9% of users, primarily due to delayed gastric emptying that may promote acid reflux

Read on as we explain